Van Hauwermeiren: 'Everyone Can Innovate'

Feb 28, 2024

Tim Van Hauwermeiren, co-founder and CEO of argenx, talks about how the biotech develops novel treatments for autoimmune conditions, why the line between success and failure is “razor thin” for fledgling companies and why innovation should happen in all corners of an organization.

WATCH: Vikram Purohit speaks with Van Hauwermeiren


When Tim Van Hauwermeiren and his co-founders started argenx in 2008, they had “no money and no business plan,” say Van Hauwermeiren. What they did have was an idea they believed in – to engineer antibodies that could ultimately change the lives of patients with autoimmune conditions.


In the latest episode of Exceptional Leaders / Exceptional Ideas, biotechnology analyst Vikram Purohit talks with Van Hauwermeiren about his entrepreneurial journey, ideas for keeping innovation front and center, and a last-minute dinner that proved pivotal for argenx and the patients whose lives have been changed by its technology. 

More Exceptional Leaders

Watch other episodes in this series from Morgan Stanley Research, as the firm’s equity analysts sit down with business leaders at world-class global companies to unpack broad foundational changes in sectors, industries and markets.

More Insights